Company Filing History:
Years Active: 2012-2013
Title: Harish K Nagaraj: Innovator in Kinase Inhibitors
Introduction
Harish K Nagaraj is a notable inventor based in Singapore, SG. He has made significant contributions to the field of medicinal chemistry, particularly in the development of purine compounds that serve as kinase inhibitors. With a total of 2 patents, his work is pivotal in addressing proliferative conditions and disorders.
Latest Patents
One of Harish's latest patents focuses on pyrimidine substituted purine derivatives. This invention relates to purine compounds that are useful as kinase inhibitors. More specifically, it encompasses methods for their preparation, pharmaceutical compositions containing these compounds, and their applications in treating various proliferative conditions or disorders. These compounds may serve as effective medicaments for treating tumors, cancers, and other disorders associated with PI3 and/or mTOR kinases.
Career Highlights
Harish K Nagaraj is currently associated with Verastem, Inc., where he continues to innovate in the field of pharmaceutical development. His expertise in kinase inhibitors has positioned him as a key player in the research and development of new therapeutic agents.
Collaborations
Harish collaborates with various professionals in his field, including his coworker Meredith Williams. Their combined efforts contribute to advancing research in kinase inhibitors and related therapeutic areas.
Conclusion
Harish K Nagaraj's contributions to the field of medicinal chemistry, particularly through his innovative patents, highlight his role as a significant inventor in the development of treatments for proliferative conditions. His work continues to impact the pharmaceutical industry positively.